Stop the War on Patients by Brent Saunders and Pfizer/Allergan

According to Forbes the present CEO of Allergan, Brent Saunders, would assume the leadership role at the newly combined company. Brent Saunders, according to Forbes, is known for his anti-research attitude. Forbes quotes him as saying, “the idea that to play in the big leagues you have to do drug discovery (research) is a fallacy.” Mr. Saunders is a profits first CEO and that’s why stockholders love him. His long standing approach as a CEO is to ramp up profits from existing drugs by raising prices while simultaneously dumping research and development of new treatments. This is not the man the public wants running the largest pharmaceutical company in the world. Making this more of a public disaster is the attempt by Pfizer to avoid paying appropriate taxes to the U.S. government by taking their assets overseas through this merger - See more at: http://www.metabolism.com/2015/11/19/end-the-war-on-patients-by-allergan-pharmaceuticals-or-is-it-actavis-or-is-it-pfizer/#more-21558